Page last updated: 2024-08-18

pyridostigmine bromide and Adenocarcinoma

pyridostigmine bromide has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Reyes-Bueno, JA; Rodriguez-Santos, L; Serrano-Castro, PJ	1

Reviews

1 review(s) available for pyridostigmine bromide and Adenocarcinoma

Article	Year
[Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases]. Revista de neurologia, 2019, Apr-16, Volume: 68, Issue:8 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Ipilimumab; Lung Neoplasms; Male; Myasthenia Gravis; Nivolumab; Pyridostigmine Bromide	2019

Article

Year

[Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases].

Revista de neurologia, 2019, Apr-16, Volume: 68, Issue:8

Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Ipilimumab; Lung Neoplasms; Male; Myasthenia Gravis; Nivolumab; Pyridostigmine Bromide

2019